1. Home
  2. OI vs CNTA Comparison

OI vs CNTA Comparison

Compare OI & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OI
  • CNTA
  • Stock Information
  • Founded
  • OI 1903
  • CNTA 2020
  • Country
  • OI United States
  • CNTA United Kingdom
  • Employees
  • OI N/A
  • CNTA N/A
  • Industry
  • OI Containers/Packaging
  • CNTA Biotechnology: Pharmaceutical Preparations
  • Sector
  • OI Consumer Discretionary
  • CNTA Health Care
  • Exchange
  • OI Nasdaq
  • CNTA Nasdaq
  • Market Cap
  • OI 2.0B
  • CNTA 2.0B
  • IPO Year
  • OI N/A
  • CNTA 2021
  • Fundamental
  • Price
  • OI $11.24
  • CNTA $15.67
  • Analyst Decision
  • OI Buy
  • CNTA Strong Buy
  • Analyst Count
  • OI 8
  • CNTA 7
  • Target Price
  • OI $16.25
  • CNTA $23.14
  • AVG Volume (30 Days)
  • OI 1.4M
  • CNTA 271.8K
  • Earning Date
  • OI 10-29-2024
  • CNTA 11-15-2024
  • Dividend Yield
  • OI N/A
  • CNTA N/A
  • EPS Growth
  • OI N/A
  • CNTA N/A
  • EPS
  • OI N/A
  • CNTA N/A
  • Revenue
  • OI $6,643,000,000.00
  • CNTA $6,853,000.00
  • Revenue This Year
  • OI N/A
  • CNTA N/A
  • Revenue Next Year
  • OI $3.01
  • CNTA N/A
  • P/E Ratio
  • OI N/A
  • CNTA N/A
  • Revenue Growth
  • OI N/A
  • CNTA N/A
  • 52 Week Low
  • OI $10.08
  • CNTA $5.58
  • 52 Week High
  • OI $17.58
  • CNTA $17.59
  • Technical
  • Relative Strength Index (RSI)
  • OI 34.33
  • CNTA 52.05
  • Support Level
  • OI $11.08
  • CNTA $14.48
  • Resistance Level
  • OI $12.86
  • CNTA $15.64
  • Average True Range (ATR)
  • OI 0.45
  • CNTA 0.67
  • MACD
  • OI -0.18
  • CNTA -0.11
  • Stochastic Oscillator
  • OI 6.98
  • CNTA 55.87

About OI O-I Glass Inc.

O-I Glass is the world's largest manufacturer of glass bottles; 70% of its revenue comes from outside the United States. O-I has a leading position in key markets such as Europe, North America, and Brazil. Beer is the primary end market for O-I's glass bottles, which are also used for wine, soda, spirits, condiments, and food. O-I is looking to maintain or expand its dominant positions in Europe, North America, and South America.

About CNTA Centessa Pharmaceuticals plc

Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include 1) SerpinPC for Hemophilia A, B, 2) LB101 for Solid Tumors, 3) ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders, 4) MGX292 Pulmonary Arterial Hypertension (PAH) and 5) Undisclosed for Solid Tumors.

Share on Social Networks: